Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in Lung Epithelium Dysplasia (TIDAL1)
NCT01405846Phase 2Terminated
- Start
- Dec 2011
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in bronchial dysplasia. Started Dec 2011; status: terminated.
02
Drugs
03
Conditions
bronchial dysplasia
Beyond the preview
Go deeper on NCT01405846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405846.